Skip to main content

Technical View: Nifty forms Doji candle for second day, take long positions only if index holds 12K

Mazhar Mohammad of Chartviewindia.in advised traders to wait for a breakout in either of the directions and should go long if index trades above 12,000 levels.

The Nifty50 remained rangebound throughout the session on October 13 and closed flat amid lower-than-expected fiscal stimulus and better quarterly earnings.

The index formed Doji kind of pattern on the daily charts, for the second consecutive session today as closing was near opening levels. A Doji candle indicates there is some indecisiveness among the bulls and the bears and bounces were being sold in the absence of follow-up buying interest.

At this juncture, as index seems to be in no trade zone, Mazhar Mohammad of Chartviewindia.in advised traders to wait for a breakout in either of the directions and should go long if index trades above 12,000 levels whereas intraday shorting should be considered below 11,867 for a modest target of 11,800.

The Nifty50 opened flat at 11,934.65 and remained in a 100 points range. It touched an intraday high of 11,988.20 and low of 11,888.90, before closing 3.5 points higher at 11,934.50.

India VIX was down by 1.96 percent from 21.12 to 20.71 levels.

"Doji candle formation on Nifty50 for two consecutive days, with narrow range of trading between 100 points, is suggesting that momentum may be slowly fizzling out among the bulls," Mazhar Mohammad, Chief Strategist – Technical Research & Trading Advisory at Chartviewindia.in told Moneycontrol.



Hence, he feels in next trading session if Nifty slips and settles below 11,867 levels then it can witness profit booking, and a close below 5-day exponential moving average, whose value is placed around 11,845, can also set the tone for a corrective down swing.

Contrary to these expectations, if bulls manage to push the index beyond 12,000 levels on closing basis then the upward swing can get extended towards 12,200 levels, according to him.

On option front, maximum Put open interest was at 10,500 followed by 11,000 strike, while maximum Call open interest was at 12,500 followed by 12,000 strike. Marginal Call writing was seen in 12,500 and 12,300 strike while Put writing was seen at 11,600 then 11,900 strike.

The abovementioned option data indicated that an immediate trading range for Nifty could be 11,700 to 12,100 levels.

Bank Nifty opened lower at 23,663.05 and remained under pressure for most part of the session to hit an intraday low of 23,431.50.

The index negated the formation of higher high - higher lows of last seven trading sessions and closed in negative mood for second consecutive session. It fell 220.60 points to 23,492.20 and formed a bearish candle on daily scale.

Chandan Taparia, Vice President | Analyst-Derivatives at Motilal Oswal Financial Services told Moneycontrol that Bank Nifty has to hold above 23,500 to witness an upmove towards 24,200 then 24,500 while on the downside key support exists at 23,200 then 23,000 levels.

He said positive setup was seen in HCL Technologies, Tata Chemicals, Infosys, Reliance Industries, Mindtree, Kotak Mahindra Bank, Ambuja Cements and Tech Mahindra while weakness was seen in LIC Housing Finance, Zee Entertainment, M&M Financial, Bosch, RBL Bank, Siemens and MGL.

Comments

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...

Brokerages place bets on Titan, see double-digit upside in the stock

Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. After three consecutive sessions of losses, shares of Titan Company rose over a percent in morning trade on BSE on September 23. The company was dealt a severe blow by COVID-19 as the pandemic triggered strict lockdowns completely battered the retail sector. In the calendar year so far, shares of this one of the largest, most efficient and profitable specialty retailer in India are 7 percent down. The company reported a net standalone loss of Rs 270 crore for the quarter ended June 2020 as the COVID-19 pandemic hit business. The loss was higher than a CNBC-TV18 poll estimate of Rs 175 crore. Standalone revenue during the quarter declined 62.3 percent year-on-year to Rs 1,862 crore compared to the corresponding period last fiscal. Light at the end ...

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...